Poietis, a French biotechnology firm, has introduced the granting of a 3rd patent for its laser-assisted 3D bioprinting methodology.
“We had been the primary to discover the economic potential of laser-assisted bioprinting know-how in numerous purposes,” acknowledged Fabien Guillemot, President and CEO of Poietis.
“The granting of this collection of European patents additional helps Poietis’ place within the area of 3D bioprinting.”
Laser-assisted 3D bioprinting
With 5 years of expertise within the medical area, Poietis’ 3D bioprinting know-how presents a novel technique of growing practical self-organizing cell constructions. “In contrast to standard approaches to tissue engineering or extrusion bioprinting, laser-assisted bioprinting permits cells to be positioned in three dimensions with micrometric decision and precision,” Poeitis states.
Its know-how is being carried out in cosmetics to manufacture pores and skin fashions, via a partnership with BASF. Poietis has additionally partnered with Servier Laboratories, a privately owned international pharmaceutical firm, to create a liver toxicity detection mannequin able to figuring out drug-induced lesions.
Most lately, the corporate has launched a 4D bioprinting methodology during which tissue self-organization is programmed by designing the preliminary tissue structure in CAD. This improves the performance of the 3D bioprinted tissues.
4D bioprinted pores and skin equal fashions. Photograph by way of Poietis.
The brand new Poietis patent
Beforehand delivered in France, the most recent patent issued by the European Patent Workplace, Patent No. EP3233499, is entitled “Laser printing methodology and gadget for implementing stated methodology.” It follows the 2017 Patent No. EP2542659 entitled “Bioprinting Station, meeting comprising such
bioprinting station and bioprinting methodology” which pertains to the difference of the printing patterns on substrates.
Furthermore, in June 2018, Poietis had been issued Patent No. EP3234102 entitled “Methodology for laser printing organic parts and gadget for implementing stated methodology”, which covers the laser-assisted bioprinting and multimodal bioprinting processes in Europe.
“The grant of those patents strengthens Poietis’ mental property asset,” defined Bruno Brisson, Basic Supervisor and VP Enterprise Growth at Poietis. “It’s also further safety of essential technological bricks which might be built-in into the NGB-R, next-gen bioprinting programs that we commercialize now.”
Voting is now open for the 2019 3D Printing Trade Awards.
For the most recent medical additive manufacturing information, subscribe to our 3D printing publication and observe us Fb and Twitter. Go to our 3D Printing Jobs board to search out out extra about alternatives in additive manufacturing.
Featured picture reveals the NGB-R 3D bioprinter manufactured a 16 layers construction. Photograph by way of Poietis.
Credit score : Supply Hyperlink